FULC earnings: a positive outcome, +19.5%

On November 7, 2023, Fulcrum Therapeutics, Inc. reached its earnings. The result was a positive outcome, and the stock moved +19.5% in the window around the event. It had already run -6.9% in the 30 days into the catalyst — the kind of pre-event run-up that often precedes binary readouts.